Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 44c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $86.81 -0.34%
Financial Fact:
TOTAL OTHER INCOME (EXPENSE): -79.26K
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
TOTAL OTHER INCOME (EXPENSE): -79.26K
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($1.24), $0.44 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $3.55 million versus the consensus estimate of $37.66 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- X Financial (XYF) Tops Q2 EPS by 438c
- Citi maintains buy ratings on Argentina power firms amid sector shifts
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
